Exploratory composite endpoint demonstrates benefit of trilaciclib across multiple clinically meaningful components of myeloprotection in patients with small cell lung cancer

Manuel Dómine Gómez, Tibor Csőszi, Jana Jaal, Iveta Kudaba, Krasimir Nikolov, Davorin Radosavljevic, Jie Xiao, Janet K. Horton, Rajesh K. Malik, Janakiraman Subramanian (Coresponding Author)

Research output: Contribution to journalArticlepeer-review

2 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Exploratory composite endpoint demonstrates benefit of trilaciclib across multiple clinically meaningful components of myeloprotection in patients with small cell lung cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences